RHBC
ELV icon

R.H. Bluestein & Co’s Elevance Health ELV Stock Holding History

R.H. Bluestein & Co’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$248K Hold
546
– – 0.02% 278
2022
Q2 		$263K Sell
546
-100
-15% -$49.5K 0.02% 281
2022
Q1 		$317K Hold
646
– – 0.01% 277
2021
Q4 		$299K Hold
646
– – 0.01% 318
2021
Q3 		$241K Hold
646
– – 0.01% 363
2021
Q2 		$247K Hold
646
– – 0.01% 368
2021
Q1 		$232K Hold
646
– – 0.01% 369
2020
Q4 		$207K Buy
+646
New +$198K 0.01% 367

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

R.H. Bluestein & Co's ELV Position: Q3 2022 in Review

R.H. Bluestein & Co held its Elevance Health (ELV) position steady in Q3 2022 at 546 shares worth $248K. The position accounts for 0.02% of the portfolio, ranked #278.

R.H. Bluestein & Co first reported a position in ELV in Q4 2020 and has held it in 8 quarters since. The position peaked at $317K in Q1 2022. 1,445 funds tracked by Wall St. Rank hold ELV as of Q3 2022.

  • R.H. Bluestein & Co held 546 shares of Elevance Health worth $248K as of Q3 2022.
  • R.H. Bluestein & Co left its Elevance Health share count unchanged in Q3 2022.
  • Elevance Health made up 0.02% of R.H. Bluestein & Co's portfolio in Q3 2022, its #278 holding.
  • R.H. Bluestein & Co first reported a position in Elevance Health in Q4 2020 and has held it in 8 quarters since.
  • R.H. Bluestein & Co's Elevance Health position peaked at $317K in Q1 2022.
  • 1,445 funds tracked by Wall St. Rank held Elevance Health as of Q3 2022.

Based on R.H. Bluestein & Co's 13F filing for Q3 2022, filed 14 Nov 2022.